Resistance to type II JAK2 inhibition in MPN is dependent on targetable MAPK activation and is reversible Meeting Abstract


Authors: Szybinski, J.; Codilupi, T.; Ghosh, N.; Passweg, J.; Tsakiris, D.; Radimerski, T.; Levine, R. L.; Meyer, S. C.
Abstract Title: Resistance to type II JAK2 inhibition in MPN is dependent on targetable MAPK activation and is reversible
Meeting Title: 2nd Swiss Hematology & Oncology Congress (SOHC)
Journal Title: Swiss Medical Weekly
Volume: 149
Issue: Suppl. 237
Meeting Dates: 2019 Jun 26-28
Meeting Location: Zurich, Switzerland
ISSN: 1424-7860
Publisher: E M H Swiss Medical Publishers Ltd  
Date Published: 2019-06-21
Start Page: 23S
Language: English
ACCESSION: WOS:000473833600059
PROVIDER: wos
Notes: Meeting Abstract: 1080 -- Source: Wos
MSK Authors
  1. Ross Levine
    503 Levine